Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Organ Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00113113
What this trial is testing

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

Who this might be right for
Tumors
Astex Pharmaceuticals, Inc. 54
Not applicableEnded earlyNCT00923052
What this trial is testing

The Natural History of Solid Organ Cancer Stem Cells (SOCSC)

Who this might be right for
Hepatic CancerPancreatic Ductal CancerColorectal Cancer+2 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Not applicableStudy completedNCT00948883
What this trial is testing

Study of Cancers After Solid Organs Transplants

Who this might be right for
CancerOrgan Transplantation
Assistance Publique - Hôpitaux de Paris 330
Not applicableStudy completedNCT03335826
What this trial is testing

Epidural Anesthesia and Long-term Outcomes in Elderly Patients After Surgery

Who this might be right for
Elderly PatientsSolid Organ CancerSurgical Resection+2 more
Peking University First Hospital 1,802
Not applicableStudy completedNCT03685539
What this trial is testing

DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center 42
Large-scale testing (Phase 3)Active Not RecruitingNCT05860881
What this trial is testing

Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)

Who this might be right for
Solid Organ Transplant RecipientsSkin Cancer
Melanoma and Skin Cancer Trials Limited 146
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Large-scale testing (Phase 3)Study completedNCT00964210
What this trial is testing

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination

Who this might be right for
Cervical Cancer
Murdoch Childrens Research Institute 240
Early research (Phase 1)Study completedNCT00002759
What this trial is testing

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more
National Cancer Institute (NCI) 3
Early research (Phase 1)UnknownNCT00024310
What this trial is testing

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00058604
What this trial is testing

Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).

Who this might be right for
Epstein-Barr Virus InfectionsLymphoproliferative Disorders
Baylor College of Medicine 12
Testing effectiveness (Phase 2)UnknownNCT03769285
What this trial is testing

Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial

Who this might be right for
Non-melanoma Skin CancerCarcinoma, Squamous CellCarcinoma, Basal Cell
Women's College Hospital 120
Not applicableLooking for participantsNCT05650125
What this trial is testing

A Platform Study for solId orgaN CancERs

Who this might be right for
CancerSurgery
University of Liverpool 2,000
Early research (Phase 1)UnknownNCT02575638
What this trial is testing

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

Who this might be right for
Malignant Lymphoma of Extranodal and/or Solid Organ SiteSolid Tumor
Cao Pharmaceuticals Inc. 65
Early research (Phase 1)Study completedNCT01218555
What this trial is testing

Study of Everolimus (RAD001) in Combination With Lenalidomide

Who this might be right for
Solid Organ MalignanciesAdenoidcystic CarcinomaNeuroendocrine Tumors
Emory University 44
Early research (Phase 1)Study completedNCT00026169
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure

Who this might be right for
Malignant NeoplasmUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 69
Not applicableStudy completedNCT04670094
What this trial is testing

Comorbidities and Risk Score in COVID-19 Patients

Who this might be right for
Covid19
University of Milano Bicocca 4,555
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Very early researchStudy completedNCT03131934
What this trial is testing

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

Who this might be right for
Post-transplant Lymphoproliferative DiseaseTransplant-Related Hematologic Malignancy
University College, London 4
Next Page
190